Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Atossa Therapeutics Inc. (ATOS)

1.22   -0.105 (-7.92%) 02-25 16:00
Open: 1.3 Pre. Close: 1.325
High: 1.33 Low: 1.21
Volume: 94,608 Market Cap: 11M
Atossa Genetics Inc is a clinical-stage pharmaceutical company engaged in the development of novel therapeutics and delivery methods for the treatment of breast cancer and other breast conditions.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 1.331 - 1.342 1.342 - 1.35
Low: 1.189 - 1.2 1.2 - 1.208
Close: 1.205 - 1.223 1.223 - 1.234

Technical analysis

as of: 2020-02-25 4:27:22 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 1.67     One year: 1.83
Support: Support1: 1.21    Support2: 1.01
Resistance: Resistance1: 1.43    Resistance2: 1.57
Pivot: 1.41
Moving Average: MA(5): 1.34     MA(20): 1.42
MA(100): 1.53     MA(250): 2.09
MACD: MACD(12,26): -0.05     Signal(9): -0.04
Stochastic oscillator: %K(14,3): 16.29     %D(3): 26.26
RSI: RSI(14): 24.78
52-week: High: 7.39  Low: 1.19  Change(%): -18.7
Average Vol(K): 3-Month: 7753  10-Days: 6652

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
ATOS has closed below the lower band by 12.7%. If price is in a downtrend band; this downward trend in price might continue. However a short term pullback inside the band is likely. Bollinger Bands are 2.4% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Atos Delivers Predictive Technology to Further Growth Trajectory at Goli Nutrition
PARIS and WEST HOLLYWOOD, Calif., Feb. 20, 2020 /PRNewswire/ -- Atos, a global leader in digital transformation, and Goli Nutrition, an innovator in health and creator of the world's first apple cider vinegar (ACV) gummy, today announce that Atos will deliver its Predictive…

Atos adds RingCentral as Preferred Provider of UCaaS Solutions
BELMONT, Calif. & PARIS--(BUSINESS WIRE)-- #Atos--Atos adds RingCentral as the preferred provider of Unified Communications as a Service (UCaaS) solutions

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ Capital Market
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 9.13
Shares Float (M) 9.10
% Held by Insiders 0.57
% Held by Institutions 3.13
Shares Short (K) 339
Shares Short P. Month (K)

Stock Financials

EPS -2.187
Book Value (p.s.) 1.570
PEG Ratio
Profit Margin
Operating Margin
Return on Assets (ttm) -68.2
Return on Equity (ttm) -130.5
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -1.829
Qtrly Earnings Growth
Operating Cash Flow (M) -8.86
Levered Free Cash Flow (M) -5.00

Stock Valuations

P/E -0.56
P/E Growth Ratio -0.08
P/BV 0.78
P/CF -1.26

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date 2018-04-19
Last Split Ratio 0.083
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.